Imcivree

Active Ingredient(s): Setmelanotide
FDA Approved: * November 25, 2020
Pharm Company: * RHYTHM PHARMACEUTICALS INC
Category: Diet / Weight Loss

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Imcivree Overview

Setmelanotide, sold under the brand name Imcivree, is a medication for the treatment of obesity.[1][2] The most common side effects include injection site reactions, skin hyperpigmentation (skin patches that are darker than surrounding skin), headache and gastrointestinal side effects (such as nausea, diarrhea, and abdominal pain), among others.[2] Spontaneous penile erections in males and adverse sexual reactions in females have occurred with t...

Read more Imcivree Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Setmelanotide

Recent Imcivree Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Setmelanotide
  • Solution: 10mg/ml, 10mg/ml (10mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Setmelanotide or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA